Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment : A comprehensive review compiled by the German Testicular Cancer Study Group.
Pfister D, Oechsle K, Schmidt S, Busch J, Bokemeyer C, Heidenreich A, Heinzelbecker J, Ruf C, Winter C, Zengerling F, Kliesch S, Albers P, Oing C. Pfister D, et al. Among authors: zengerling f. World J Urol. 2022 Dec;40(12):2853-2861. doi: 10.1007/s00345-022-03959-8. Epub 2022 Feb 28. World J Urol. 2022. PMID: 35226138 Free PMC article. Review.
German second-opinion network for testicular cancer: sealing the leaky pipe between evidence and clinical practice.
Zengerling F, Hartmann M, Heidenreich A, Krege S, Albers P, Karl A, Weissbach L, Wagner W, Bedke J, Retz M, Schmelz HU, Kliesch S, Kuczyk M, Winter E, Pottek T, Dieckmann KP, Schrader AJ, Schrader M; GTCSG (German Testicular Cancer Study Group). Zengerling F, et al. Oncol Rep. 2014 Jun;31(6):2477-81. doi: 10.3892/or.2014.3153. Epub 2014 Apr 24. Oncol Rep. 2014. PMID: 24788853 Free PMC article.
Male Extragonadal Germ Cell Tumors of the Adult.
Busch J, Seidel C, Zengerling F. Busch J, et al. Among authors: zengerling f. Oncol Res Treat. 2016;39(3):140-4. doi: 10.1159/000444271. Epub 2016 Feb 23. Oncol Res Treat. 2016. PMID: 27032104 Review.
[Antioxidants for male subfertility].
Zengerling F, Schmidt S. Zengerling F, et al. Urologe A. 2016 Jul;55(7):956-9. doi: 10.1007/s00120-016-0146-x. Urologe A. 2016. PMID: 27315809 Review. German. No abstract available.
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G. Dieckmann KP, et al. Among authors: zengerling f. J Clin Oncol. 2019 Jun 1;37(16):1412-1423. doi: 10.1200/JCO.18.01480. Epub 2019 Mar 15. J Clin Oncol. 2019. PMID: 30875280 Free PMC article.
Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer.
Sibert NT, Dieng S, Oesterle A, Feick G, Carl G, Steiner T, Minner J, Roghmann F, Kaftan B, Zengerling F, Hinkel A, Beyer B, Heidenreich A, Harke N, Brehmer B, Pfitzenmaier J, Fichtner J, Neisius A, Hammerer P, Wesselmann S, Kowalski C. Sibert NT, et al. Among authors: zengerling f. World J Urol. 2021 Jan;39(1):11-25. doi: 10.1007/s00345-019-02949-7. Epub 2019 Sep 24. World J Urol. 2021. PMID: 31552467
106 results